drugset
drugset / Trial / NCT07693036

hUC-MSC-Exosomes for T2DM - Safety & Efficacy

NCT07693036 ↗

Phase 1/2 Recruiting 66 enrolled Peking University First Hospital ECHO Biotech · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this clinical trial is to Evaluate the Safety and Preliminary Efficacy of Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Adult Type 2 Diabetes Mellitus.

Timeline

Start
2026-06-05
Primary completion
2028-06-04
Completion
2028-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject GoldenExo Unknown 1e+11 unknown Intravenous
Subject GoldenExo Unknown 3e+11 unknown Intravenous
Subject GoldenExo Unknown 9e+11 unknown Intravenous

Indications

type 2 diabetes mellitus